BridgeMD
Extension Study to Assess Batoclimab in Participants with TED.
EU CTIS ID: 2024-512650-21-00
What this study is testing
To describe batoclimab maintenance of efficacy as assessed by proptosis.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- For all participants: have completed the Week 24 visit of the feeder study.
- For participants assigned to the Open-label Treatment Cohort: 1. Do not require immediate surgical intervention and is not planning corrective surgery/irradiation or medical therapy for TED during the course of the study. 2. Did not permanently discontinue study drug.
You likely can't join if
- For all participants: in the Investigator's judgement, the benefits of entry in the study do not outweigh the risk.
The study team makes the final eligibility decision.
Where it's taking place
- Georgia
- United Kingdom
- United States
- Canada
- Turkey
- New Zealand
- Israel
- Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Georgia; United Kingdom; United States; Canada; Turkey; New Zealand and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.